ClinicalTrials.Veeva

Menu

Predict the Risk of Axillary Metastases in Breast Cancer Patients With Axillary Ultrasound

Sun Yat-sen University logo

Sun Yat-sen University

Status

Unknown

Conditions

Breast Cancer Female

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Axillary lymph node status is a vital prognostic factors in breast cancer patients and provides crucial information for making treatment decisions.This projective observational study is planned to identify risk factors for axillary metastases in breast cancer patients with axillary ultrasound and to construct a nomogram to predict the risk of axillary metastases in these patients.

Full description

Breast carcinoma is the most common malignancy in women, accounting for 25% of all female cancer cases and 15% of all cancer-related deaths in the world.Lymph node metastasis is a multifactorial event. Among patients with a preoperative axillary ultrasound, almost 40% of patients are pathologically proved to be free from axillary metastasis.The purpose of this study is to develop a nomogram to evaluate the probability of axillary metastasis as a tool to support clinical decision-making.

Enrollment

120 estimated patients

Sex

Female

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • female patients with primary breast cancer
  • receiving a successful SLNB or ALND
  • pathological diagnosed, without distant metastasis
  • a clinically negative axilla

Exclusion criteria

  • pregnancy
  • neoadjuvant therapy
  • previous ipsilateral axillary surgery
  • inflammatory breast cancer

Trial contacts and locations

1

Loading...

Central trial contact

Jianguo Lai, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems